Company / Book Value per Share
NewAmsterdam Pharma Co N.V. Book Value per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$5.771
FY2025
5-year range
-$10.367 / $22.675
FY2021-FY2025
Trend
-28.1%
vs FY2024
Sector context
#95 of 207
Health Care
What the data says
At $5.771, NewAmsterdam Pharma Co N.V.'s book value per share ranks #95 of 207 in the Health Care sector. Book Value per Share has fluctuated over the past 5 years, ranging from -$10.367 in FY2021 to $22.675 in FY2022.
Based on SEC 10-K filings.
$5.771 in FY2025 with a 3-year CAGR of -36.6%.
Improved from $3.51 to $5.771 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -36.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#95 of 207 in Health CareTop 46% of 207This company $5.771 Sector average $208.468
▼
-97.2% below sector average
Key checks
Key Insights
- 3-year CAGR of -36.6%, indicating a declining trend.
- In FY2025, book value per share decreased 28.1% year-over-year.
- Ranks #95 out of 207 companies in the Health Care sector.
- Peak book value per share was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.01 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.771 | -28.1% |
| FY2024 | $8.028 | +128.7% |
| FY2023 | $3.51 | -84.5% |
| FY2022 | $22.675 | +318.7% |
| FY2021 | -$10.367 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026